2012
MicroRNAs and Renal Cell Carcinoma
RÉDOVÁ, Martina; Jaroslav MICHÁLEK and Ondřej SLABÝBasic information
Original name
MicroRNAs and Renal Cell Carcinoma
Authors
RÉDOVÁ, Martina (203 Czech Republic, guarantor, belonging to the institution); Jaroslav MICHÁLEK (203 Czech Republic) and Ondřej SLABÝ (203 Czech Republic, belonging to the institution)
Edition
New York, MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets, p. 121-128, 8 pp. 2012
Publisher
Nova Science Publishers, Inc.
Other information
Language
English
Type of outcome
Chapter(s) of a specialized book
Field of Study
30200 3.2 Clinical medicine
Country of publisher
United States of America
Confidentiality degree
is not subject to a state or trade secret
Publication form
printed version "print"
RIV identification code
RIV/00216224:14740/12:00060173
Organization unit
Central European Institute of Technology
ISBN
978-1-61324-514-9
Keywords in English
microRNAs; renal cell carcinoma
Tags
International impact, Reviewed
Changed: 19/3/2013 08:56, Olga Křížová
Abstract
In the original language
Renal cell carcinoma (RCC) is the most common neoplasm of the adult kidney accounting for about 3 % of adult malignancies. As the role of miRNAs in RCC pathogenesis is emerging, it has been postulated that miRNAs can serve as new potential biomarkers that may improve diagnostic, prognostic and predictive abilities, and consequently, the management of RCC patients.
Links
| ED1.1.00/02.0068, research and development project |
|